Vaccine safety and effectiveness are patients’ biggest concerns about a potential coronavirus disease 2019 (COVID-19) vaccine, says Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.
Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing, addresses concerns patients may have about a potential coronavirus vaccine and its likely distribution protocol.
Transcript
What concerns have patients expressed to you most about a potential coronavirus vaccine?
I think the 2 biggest fears are generally they fear the safety of the vaccine and how well it’s going to work. And I think that’s common in any new medication, any sort of thing that we derive from a clinical trial, whether it be the COVID [coronavirus disease 2019] vaccine or anything else. And I think people are worried about that, about vaccines in general. We know people have fears about vaccines in general. So I don’t think there’s anything new.
I think what’s unique to this is the fact that it’s a quicker timeline for vaccine development than other vaccines of the past, and so I think people are concerned that, you know, there are steps that may be skipped or rushed. But there’s no evidence that that’s actually going on at all. In fact, we’re roughly in the same process. It’s just working together.
What is the protocol to ensure vaccine delivery to patients? How is priority determined?
Just to kind of go through how normal, or historical vaccines—ones we currently use that are approved—are distributed is that you can place an order, say, from your vendor for the amount of flu vaccine that you want for the year and you purchase it, and it’s delivered to you and then to the disbursement site for patients.
I think what we don’t know yet for this is how that process will go. I don’t think it’s been developed yet because the vaccine is not developed. But again, it’ll be similar in the fact that there’ll be sites to which it’s dispersed so that it can be dispensed to patients. In terms of what sites those are and who will be first priority, that has not yet been determined. There’s been some discussion about high-risk patients, essential frontline workers, but again, that hasn’t been 100% decided and eventually that’ll be decided by public health officials and clinicians and scientists, most likely.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More